Home › INDIAGLYCO › Filing
🔔 Get instant alerts when INDIAGLYCO files quarterly results on BSE Start free trial →
India Glycols Limited (INDIAGLYCO)

Investor Presentation

Filed: 18 Nov 2026, 15:39 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2 & H1 FY27 - Q2 FY27 revenue grew 30% YoY to ₹358 Cr; H1 revenue up 26% to ₹713 Cr - EBITDA rose 26% in Q2 to ₹52 Cr and 25% in H1 to ₹113 Cr; H1 margin stable at 15.8% - Bio-based Specialty Materials revenue up 43% in H1 to ₹382 Cr; EBITDA up 15% to ₹62 Cr - Sustainable & Performance Chemicals revenue up 36% in Q2 to ₹167 Cr; EBITDA up 49% to ₹24 Cr; margin expanded to 14.2% - Outlook: steady growth in specialty materials; performance chemicals growth driver with new products pipeline - Demerger completed; IGL now a pure-play chemicals company focused on specialty materials - Strong structural shift towards specialty-led portfolio with margin expansion potential
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 INDIAGLYCO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add INDIAGLYCO to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on India Glycols Limited

Important. The summary above is generated automatically from India Glycols Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.